Price
Target price
?
?
0.000%
-
0.000%
-
08:07 / Frankfurt
WKN: 984345 / Name: HBM Healthcare / Stock / Investment Banking & Investment Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for HBM Healthcare
sharewise wants to provide you with the best news and tools for HBM Healthcare, so we directly link to the best financial data sources.
Financials
News
HBM Healthcare Investments publishes Quarterly Report as at 30 June 2026 with key figures for the first three months of the 2026/2027 financial year
HBM Healthcare Investments publishes Quarterly Report as at 30 June 2026 with key figures for the first three months of the 2026/2027 financial year
HBM Healthcare Investments delivers strong quarterly performance, expects profit of CHF 238 million
HBM Healthcare Investments delivers strong quarterly performance, expects profit of CHF 238 million
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
HBM Healthcare Investments benefits from successful IPO of Parabilis Medicines
HBM Healthcare Investments benefits from successful IPO of Parabilis Medicines
HBM Healthcare Investments Announces Closing of Swixx Biopharma Transaction with SK Capital and Bain Capital Life Sciences
HBM Healthcare Investments Announces Closing of Swixx Biopharma Transaction with SK Capital and Bain Capital Life Sciences
Eli Lilly to Acquire HBM Portfolio Company Curevo for up to USD 1.5 Billion
Eli Lilly to Acquire HBM Portfolio Company Curevo for up to USD 1.5 Billion
HBM Healthcare Investments posts profit of CHF 272 million in its 25th financial year
HBM Healthcare Investments posts profit of CHF 272 million in its 25th financial year
HBM Healthcare Investments increases NAV by 17.2 percent and expects annual profit of CHF 272 million for the 2025/2026 financial year
HBM Healthcare Investments increases NAV by 17.2 percent and expects annual profit of CHF 272 million for the 2025/2026 financial year
Merck to Acquire HBM Portfolio Company Terns Pharmaceuticals for USD 6.7 Billion
Merck to Acquire HBM Portfolio Company Terns Pharmaceuticals for USD 6.7 Billion